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LETTERS TO THE EDITOR
Flail Mitral Valve and Sudden Cardiac Death
The recent report by Grigioni et al. (1) of an increased risk of
sudden death in mitral regurgitation due to a flail leaflet was of
interest to us, and we are sure, to many other cardiologists.
Certainly, the Mayo Clinic group has been instrumental in
advancing our understanding of the natural history of patients with
mitral regurgitation. Specifically, Grigioni et al. (1) presented data
suggesting that patients with a flail mitral leaflet, even in the
absence of severe symptoms and left ventricular dysfunction, incur
an enhanced risk of sudden unexpected death due to their valvular
abnormality. As suggested in the accompanying editorial by
Carabello (2), the potentially important role of associated athero-
sclerotic coronary disease in causing these sudden deaths could not
be excluded, particularly given the rather advanced ages of those
patients who died (mean age 71 years). Of the 25 sudden deaths,
coronary artery disease was excluded in only four, and seven other
patients were said to have a history consistent with this condition.
We wonder: if such patients, who are likely to have ischemic heart
disease (an alternative cause for sudden death at an advanced age),
had been segregated in the authors’ sophisticated statistical anal-
ysis, would their results and conclusions have been as definitive?
Perhaps under these circumstances, the authors should have been
more conservative in their conclusions: “Sudden death is relatively
common in patients with mitral regurgitation–flail leaflet who are
conservatively managed,” as well as in the attractive title of the
paper: “Sudden Death in Mitral Regurgitation Due to Flail
Leaflet,” rather than potentially over-estimating the consequences
of the flail mitral valve to clinicians.
A second area of concern involves issues related to mitral valve
anatomy. Although we assume that the etiology of the flail leaflets
and mitral regurgitation in most of the patients of Grigioni et al.
(1) is mitral valve prolapse (i.e., myxomatous degeneration) with
chordal disruption, this is not explicitly stated. Flail leaflets
demonstrate a broad morphologic and functional spectrum, and
there appears to be some uncertainty as to whether relatively mild
or moderate degrees of flail (due to localized chordal disruption)
were included among the authors’ study group of 348 patients, who
have been characterized in the report as being at increased risk for
sudden death. Should patients with relatively mild or segmental
flail leaflets also be regarded to be at increased risk? Are the authors
suggesting that all patients with flail segments represent a distinct
subgroup within the mitral valve prolapse spectrum, as apposed to
other patients with prolapse with moderate to severe mitral
regurgitation, such as those with elongated chordae? Perhaps a
clarification of these points would help clinicians better appreciate
the potential consequences of the flail mitral valve.
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REPLY
We appreciate the interest of Drs. Harris and Maron regarding our
recent article in JACC (1). In their comments, Drs. Harris and
Maron raised the question of an “increased” or “enhanced” risk of
sudden death in mitral regurgitation due to a flail leaflet. We did
not use such terms, because there is no available method to
compare the rates of sudden death between patients and the
general population. Therefore, it is impossible to determine
whether rates of sudden death are statistically in excess of those
observed in the population. This is an important limitation of all
studies on sudden death. Age-stratified rates of sudden death were
reported in the Framingham Study (2). An informal comparison of
those rates suggests that at similar ages, rates of sudden death in
mitral regurgitation due to a flail leaflet (without risk factors for
sudden death) are approximately twice those observed in the
general population (0.8% vs. 0.37%). Hence, the terms “relatively
common” or “notable” seem more appropriate to describe the rates
of sudden death observed in mitral regurgitation due to a flail
leaflet.
The issue raised regarding coronary artery disease (CAD) is an
important one. The age of patients with a flail leaflet is also an age
at which there is a relatively high prevalence of CAD. However, as
in our study, practicing cardiologists usually assess the risk of
sudden death without the information provided by coronary
angiography, a test usually performed only preoperatively. If we
examine, as suggested by Drs. Harris and Maron, patients without
a history of possible CAD, the 10-year rate of sudden death is
17.2 6 4.7%. In patients in functional class I or II, with an ejection
fraction $60%, no atrial fibrillation and no history of possible
CAD, the linearized sudden death rate is 0.86% per year. There-
fore, accounting for a history of clinically overt coronary disease
would not have modified the conclusion of our study. Both the
notable rate of sudden death in patients with mitral regurgitation
due to a flail leaflet and the decreased rate of sudden death
observed after mitral regurgitation surgery suggest a link between
mitral regurgitation and this dreadful event.
The other question raised by Drs. Harris and Maron is about the
concept of mitral valve prolapse and flail leaflets. Contrary to the
statement of Drs. Harris and Maron, the criteria for a diagnosis of
a flail leaflet (page 2079, Methods) and the cause of a flail leaflet
(page 2079, Results) are explicitly mentioned. We are not aware of
criteria supporting the description of mild, moderate or severe
degrees of flail leaflets mentioned by Drs. Harris and Maron. In
contrast, the degree of mitral regurgitation can be assessed and is
mentioned in the Results section. Among the 317 patients in
whom the degree of mitral regurgitation was graded, 82% had
grade III or IV mitral regurgitation. Nevertheless, the comments
of Drs. Harris and Maron raise an important question that will
need to be addressed in future studies. The respective risks of
sudden death attached to the degree of mitral regurgitation, left
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